⚡️🇺🇸#LLY #отчетность
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Revenue: USD6.74B (est USD6.61B)
Adj EPS: USD1.53 (est USD1.89)
#прогноз Sees FY Revenue: USD26.8B To USD27.4B (saw: USD26.6B To USD27.6B)
Still Sees FY Adj EPS: USD7.80 To USD8.00 (est: USD7.87)
Lilly Delivers Strong Second-Quarter 2021 Financial Results, Updates 2021 Financial Guidance
Revenue: USD6.74B (est USD6.61B)
Adj EPS: USD1.53 (est USD1.89)
#прогноз Sees FY Revenue: USD26.8B To USD27.4B (saw: USD26.6B To USD27.6B)
Still Sees FY Adj EPS: USD7.80 To USD8.00 (est: USD7.87)
⚡️🇺🇸#CLX #отчетность
Clorox Reports Fourth Quarter and Fiscal Year 2021 Results, Provides Fiscal Year 2022 Outlook
9% sales decrease (10% organic sales1 decrease)
78 cents diluted EPS (68% decrease versus year-ago quarter)
95 cents adjusted EPS2 (61% decrease versus year-ago quarter)
Clorox Reports Fourth Quarter and Fiscal Year 2021 Results, Provides Fiscal Year 2022 Outlook
9% sales decrease (10% organic sales1 decrease)
78 cents diluted EPS (68% decrease versus year-ago quarter)
95 cents adjusted EPS2 (61% decrease versus year-ago quarter)
⚡️🇺🇸#SAGE #отчетность
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
Q2 GAAP EPS of -$1.83 misses by $0.15.
Revenue of $1.64M (+50.5% Y/Y) misses by $0.37M.
Continued pipeline expansion and acceleration advancing all three brain health franchises, including first patient dosed in SAGE-718 PARADIGM Parkinson’s disease Study Part B and initiation of Phase 1 program for SAGE-689.
Sage Therapeutics Announces Second Quarter 2021 Financial Results and Highlights Pipeline and Business Progress
Q2 GAAP EPS of -$1.83 misses by $0.15.
Revenue of $1.64M (+50.5% Y/Y) misses by $0.37M.
Continued pipeline expansion and acceleration advancing all three brain health franchises, including first patient dosed in SAGE-718 PARADIGM Parkinson’s disease Study Part B and initiation of Phase 1 program for SAGE-689.
☢️#BTC #крипто #наблюдение #макро
Glassnode: Ончейн-данные в BTC указывают на схожесть процесса накопления сейчас с процессом накопления в начале-середине 2018 года
Glassnode:разница в том, что в 2021г у долгосрочных холдеров во владении на 10% больше предложения BTC
Glassnode: Ончейн-данные в BTC указывают на схожесть процесса накопления сейчас с процессом накопления в начале-середине 2018 года
Glassnode:разница в том, что в 2021г у долгосрочных холдеров во владении на 10% больше предложения BTC
⚠️🇺🇸🌎#сша #геополитика #макро
США начинают крупнейшие за последние 40 лет военно-морские учения с участием 36 кораблей и Корпуса морской пехоты в 17 часовых поясах - ТАСС
США начинают крупнейшие за последние 40 лет военно-морские учения с участием 36 кораблей и Корпуса морской пехоты в 17 часовых поясах - ТАСС
🇷🇺#GAZP
Газпром и Русгаздобыча планируют создать сп для Тамбея в 2021 г, перевести лицензии на него в 2022 г - глава Русгаздобычи - Прайм
Газпром и Русгаздобыча планируют создать сп для Тамбея в 2021 г, перевести лицензии на него в 2022 г - глава Русгаздобычи - Прайм
⚡️🇨🇳#BABA #отчетность
Alibaba Group Announces June Quarter 2021 Results
Revenue: Yuan 205.74B (est Yuan 209.38B)
Adj EPS Per ADS: 16.60 Yuan (est Yuan 14.45)
Cloud Revenue: 16.05B Yuan (est 16.98B Yuan)
Adj EBITDA: 48.63B Yuan (est 46.68B Yuan)
💥#buyback увеличен buyback Boosts Share Buyback To USD15B From USD10B
Alibaba Group Announces June Quarter 2021 Results
Revenue: Yuan 205.74B (est Yuan 209.38B)
Adj EPS Per ADS: 16.60 Yuan (est Yuan 14.45)
Cloud Revenue: 16.05B Yuan (est 16.98B Yuan)
Adj EBITDA: 48.63B Yuan (est 46.68B Yuan)
💥#buyback увеличен buyback Boosts Share Buyback To USD15B From USD10B
⚡️🇺🇸#UAA
Under Armour Reports Second Quarter 2021 Results; Raises Full Year Outlook
Q2 Non-GAAP EPS of $0.24 beats by $0.18;
GAAP EPS of $0.13 beats by $0.10.
Revenue of $1.35B (+90.8% Y/Y) beats by $130M.
Under Armour Reports Second Quarter 2021 Results; Raises Full Year Outlook
Q2 Non-GAAP EPS of $0.24 beats by $0.18;
GAAP EPS of $0.13 beats by $0.10.
Revenue of $1.35B (+90.8% Y/Y) beats by $130M.
⚡️🇺🇸#MAR #отчетность
Marriott International Reports Second Quarter 2021 Results
Second quarter reported net income totaled $422 million, compared to reported net loss of $234 million in the year-ago quarter. Second quarter adjusted net income totaled $260 million, compared to second quarter 2020 adjusted net loss of $184 million;
Adjusted EBITDA totaled $558 million in the 2021 second quarter, compared to second quarter 2020 adjusted EBITDA of $61 million;
Marriott International Reports Second Quarter 2021 Results
Second quarter reported net income totaled $422 million, compared to reported net loss of $234 million in the year-ago quarter. Second quarter adjusted net income totaled $260 million, compared to second quarter 2020 adjusted net loss of $184 million;
Adjusted EBITDA totaled $558 million in the 2021 second quarter, compared to second quarter 2020 adjusted EBITDA of $61 million;
⚡️🇺🇸#COP #отчетность
ConocoPhillip Reports Second Quarter 2021 Results
Q2 Non-GAAP EPS of $1.27 beats by $0.14;
GAAP EPS of $1.55 beats by $0.43.
Produced 1,547 MBOED excluding Libya.
Cash provided by operating activities was $4.3 billion. Excluding working capital, cash from operations (NASDAQ:CFO) of $4.0 billion exceeded capital expenditures and investments of $1.3 billion, generating free cash flow (NYSE:FCF) of approximately $2.8 billion.
ConocoPhillip Reports Second Quarter 2021 Results
Q2 Non-GAAP EPS of $1.27 beats by $0.14;
GAAP EPS of $1.55 beats by $0.43.
Produced 1,547 MBOED excluding Libya.
Cash provided by operating activities was $4.3 billion. Excluding working capital, cash from operations (NASDAQ:CFO) of $4.0 billion exceeded capital expenditures and investments of $1.3 billion, generating free cash flow (NYSE:FCF) of approximately $2.8 billion.
⚡️🇺🇸#DISCA #отчетность
Discovery A - Q2
GAAP EPS of $1.01 beats by $0.50.
Revenue of $3.06B (+20.5% Y/Y) beats by $80M.
Total U.S. Networks revenues increased 12% to $1.973B.
Adjusted OIBDA decreased 1% to $1.05B vs. consensus of $1.07B
Discovery A - Q2
GAAP EPS of $1.01 beats by $0.50.
Revenue of $3.06B (+20.5% Y/Y) beats by $80M.
Total U.S. Networks revenues increased 12% to $1.973B.
Adjusted OIBDA decreased 1% to $1.05B vs. consensus of $1.07B
⚡️🇺🇸#PSX #отчетность
Phillips 66 Q221 Earnings:
Adj EPS: USD0.74 (est USD0.56)
Chemicals Adj Earnings: USD657M (est USD538.6M)
Midstream Adj Earnings: USD316M (est USD348.7M)
Phillips 66 Q221 Earnings:
Adj EPS: USD0.74 (est USD0.56)
Chemicals Adj Earnings: USD657M (est USD538.6M)
Midstream Adj Earnings: USD316M (est USD348.7M)
🇺🇸#INCY #отчетность
Incyte Q2
Non-GAAP EPS of $0.80 beats by $0.06;
GAAP EPS of $0.67 beats by $0.12.
Revenue of $705.71M (+2.6% Y/Y) beats by $18.76M.
Jakafi (ruxolitinib) revenues of $529M in Q2 2021 (+12% vs Q2 2020)
FY21 Outlook: Jakafi (ruxolitinib) revenues of $2,125M - $2,170M from prior uidance of $2,125M - $2,20M.
Incyte Q2
Non-GAAP EPS of $0.80 beats by $0.06;
GAAP EPS of $0.67 beats by $0.12.
Revenue of $705.71M (+2.6% Y/Y) beats by $18.76M.
Jakafi (ruxolitinib) revenues of $529M in Q2 2021 (+12% vs Q2 2020)
FY21 Outlook: Jakafi (ruxolitinib) revenues of $2,125M - $2,170M from prior uidance of $2,125M - $2,20M.
This media is not supported in your browser
VIEW IN TELEGRAM
💥🇺🇸#CME #биржи #объемы #отчетность
рекордный июль по торговым объемам для CME
CME Group: Highest-Ever July Average Daily Volume
CME Posts Busiest July Ever with Average Daily Volume of 3.2 Million, Up 29 Percent Over Prior Year
рекордный июль по торговым объемам для CME
CME Group: Highest-Ever July Average Daily Volume
CME Posts Busiest July Ever with Average Daily Volume of 3.2 Million, Up 29 Percent Over Prior Year